CMMB
Chemomab TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Nebokitug now has an unusually clear regulatory path for PSC for a company this small: single pivotal Phase 3 design, no biopsy requirement, no confirmatory study requirement, and additional FDA CMC/toxology flexibility. Combined with positive Phase 2 and OLE biomarker data, that creates asymmetric upside if Chemomab secures funding or a partner [#PR-2025-02-19] [#PR-2025-03-27] [#6-K-2026-03-19].
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Further dilution remains a core risk despite runway guidance through Q1 2027.
Momentum
84
Value
44
Sentiment
54
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.50 · Bull $4.00 · Bear $0.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-05-29 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $17.50
Why
Momentum84 · Δ7d -
Value44 · Δ7d +0.1
Sentiment54 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
84
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
44
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
54
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 83.8 / Value 44.0 / Sentiment 53.8
Fundamentals (TTM)As of 2026-05-29
Fundamentals (TTM)
As of 2026-05-29
Market Cap
$14.4M
Beta
0.55
Shares Out
492.41M
P/E (TTM) · Derived
-0.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.94
Rev YoY
-
EPS YoY
+91.1%
Gross Margin
-
Op Margin
-
Net Debt
-$14.27M
Current Ratio
10.49
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology